Jing Liu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Highly Efficient

Helicobacter Pylori

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Liu, Xiaomin Jiang, Youyou Li, Kaiting Yang, Ralph R Weichselbaum, Wenbin Lin
Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy. ACS nano 18 (6) (2024)
Xiaomin Jiang, Taokun Luo, Kaiting Yang, Morten J Lee, Jing Liu, Langston Tillman, Wenyao Zhen, Ralph R Weichselbaum, Wenbin Lin
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition. Science advances 10 (29) (2024)
Xiaomin Jiang, Taokun Luo, Kaiting Yang, Morten J Lee, Jing Liu, Langston Tillman, Wenyao Zhen, Ralph R Weichselbaum, Wenbin Lin
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition. Science advances 10 (29) (2024)
Jing Liu, Xiaomin Jiang, Youyou Li, Kaiting Yang, Ralph R Weichselbaum, Wenbin Lin
Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy. ACS nano 18 (6) (2024)
Jing Liu, Xiaomin Jiang, Youyou Li, Kaiting Yang, Ralph R Weichselbaum, Wenbin Lin
Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy. ACS nano 18 (6) (2024)
Xiaomin Jiang, Taokun Luo, Kaiting Yang, Morten J Lee, Jing Liu, Langston Tillman, Wenyao Zhen, Ralph R Weichselbaum, Wenbin Lin
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition. Science advances 10 (29) (2024)
Jing Liu, Xiaomin Jiang, Youyou Li, Kaiting Yang, Ralph R Weichselbaum, Wenbin Lin
Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy. ACS nano (2024)
Xiaomin Jiang, Taokun Luo, Kaiting Yang, Morten J Lee, Jing Liu, Langston Tillman, Wenyao Zhen, Ralph R Weichselbaum, Wenbin Lin
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition. Science advances 10 (29) (2024)